HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beata Jastrzebska Selected Research

Opsins

1/2022The vitamin A transporter STRA6 adjusts the stoichiometry of chromophore and opsins in visual pigment synthesis and recycling.
10/2018Protective Effect of a Locked Retinal Chromophore Analog against Light-Induced Retinal Degeneration.
1/2017Complex binding pathways determine the regeneration of mammalian green cone opsin with a locked retinal analogue.
3/2014Inherent instability of the retinitis pigmentosa P23H mutant opsin.
1/2013Autosomal recessive retinitis pigmentosa E150K opsin mice exhibit photoreceptor disorganization.
8/2006Autosomal recessive retinitis pigmentosa and E150K mutation in the opsin gene.
12/2004A naturally occurring mutation of the opsin gene (T4R) in dogs affects glycosylation and stability of the G protein-coupled receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beata Jastrzebska Research Topics

Disease

11Retinitis Pigmentosa (Pigmentary Retinopathy)
10/2022 - 12/2004
8Retinal Degeneration
10/2022 - 12/2004
3Retinal Diseases
10/2022 - 01/2017
3Blindness (Hysterical Blindness)
01/2022 - 07/2011
2Macular Degeneration (Age-Related Maculopathy)
11/2020 - 10/2018
1Neuroinflammatory Diseases
11/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Gastroesophageal Reflux (GERD)
06/2020
1Infections
06/2020
1Virus Diseases (Viral Diseases)
01/2020
1COVID-19
01/2020
1Eye Diseases (Eye Disease)
01/2019
1Night Blindness (Nyctalopia)
10/2018
1Stargardt Disease
10/2018
1Leber Congenital Amaurosis
01/2018
1Neoplasms (Cancer)
03/2009
1Ehrlich Tumor Carcinoma
08/2002
1Neuroblastoma
06/2002

Drug/Important Bio-Agent (IBA)

9Rhodopsin (Visual Purple)IBA
01/2022 - 01/2013
7OpsinsIBA
01/2022 - 12/2004
4RetinoidsIBA
10/2022 - 01/2018
4Retinaldehyde (Retinal)IBA
01/2022 - 10/2018
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2022 - 06/2020
3Rod OpsinsIBA
10/2022 - 01/2013
3Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2006
2FlavonoidsIBA
01/2022 - 01/2021
2QuercetinIBA
11/2021 - 01/2021
2PolyphenolsIBA
11/2020 - 01/2019
1myricetinIBA
01/2021
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
01/2021
1Cone OpsinsIBA
01/2021
1Famotidine (Pepcid)FDA LinkGeneric
06/2020
1Pharmaceutical PreparationsIBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1Retinal Pigments (Pigments, Visual)IBA
10/2018
1LigandsIBA
10/2018
19-cis-retinalIBA
10/2018
1Therapeutic UsesIBA
01/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2014
1LipidsIBA
07/2011
1Contrast MediaIBA
03/2009
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2009
1S100 Proteins (S 100 Protein)IBA
08/2002
1S100 Calcium Binding Protein A6IBA
06/2002
1Carrier Proteins (Binding Protein)IBA
06/2002
1ThapsigarginIBA
06/2002
1Serine (L-Serine)FDA Link
06/2002
11,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterIBA
06/2002

Therapy/Procedure

4Therapeutics
11/2020 - 04/2014
1Intravenous Administration
06/2020